The aim of this longitudinal study is to explore whether the overall SLE disease activity and serum IFN-α levels over time are associated with negative effects on the brain regarding (i) higher plasma NfL concentrations as an indicator of increased neuronal damage, (ii) structural alterations on MRI, and (iii) cognitive dysfunction upon testing. The gene discussed is IFNA1; the disease is systemic lupus erythematosus.